<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Interdiscip Perspect Infect Dis</journal-id><journal-id journal-id-type="publisher-id">IPID</journal-id><journal-title-group><journal-title>Interdisciplinary Perspectives on Infectious Diseases</journal-title></journal-title-group><issn pub-type="ppub">1687-708X</issn><issn pub-type="epub">1687-7098</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19277099</article-id><article-id pub-id-type="pmc">2648622</article-id><article-id pub-id-type="doi">10.1155/2008/175285</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Probiotic Bacteria Influence the Composition and  Function of the Intestinal Microbiota</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>O'Toole</surname><given-names>Paul W.</given-names></name><xref ref-type="aff" rid="I1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Cooney</surname><given-names>Jakki C.</given-names></name><xref ref-type="aff" rid="I2"><sup>2</sup></xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Department  of Microbiology and Alimentary Pharmabiotic Centre, University College Cork, Cork, Ireland</aff><aff id="I2"><sup>2</sup>Department of Life Sciences and Materials and Surface Sciences Institute, University of Limerick, Limerick, Ireland</aff><author-notes><corresp id="cor1">*Paul W. O'Toole: <email>pwotoole@ucc.ie</email></corresp><fn fn-type="other"><p>Recommended by Robert A. Britton</p></fn></author-notes><pub-date pub-type="ppub"><year>2008</year></pub-date><pub-date pub-type="epub"><day>3</day><month>12</month><year>2008</year></pub-date><volume>2008</volume><elocation-id>175285</elocation-id><history><date date-type="received"><day>18</day><month>7</month><year>2008</year></date><date date-type="accepted"><day>29</day><month>9</month><year>2008</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2008 P. W. O'Toole and J. C. Cooney.</copyright-statement><copyright-year>2008</copyright-year><license license-type="open-access"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Probiotics have a range of proposed health benefits for the consumer, which may include modulating the levels of beneficial elements in the microbiota. Recent investigations using molecular approaches have revealed a human intestinal microbiota comprising over 1000 phylotypes. Mechanisms whereby probiotics impact on the intestinal microbiota include competition for substrates, direct antagonism by inhibitory substances, competitive exclusion, and potentially host-mediated effects such as improved barrier function and altered immune response. We now have the microbial inventories and genetic blueprints to begin tackling intestinal microbial ecology at an unprecedented level of detail, aided by the understanding that dietary components may be utilized differentially by individual phylotypes. Controlled intervention studies in humans, utilizing latest molecular technologies, are required to consolidate evidence for bacterial species that impact on the microbiota. Mechanistic insights should be provided by metabolomics and other analytical techniques for small molecules. Rigorous characterization of interactions between the diet, microbiota, and probiotic bacteria will provide new opportunities for modulating the microbiota towards improving human health.</p></abstract></article-meta></front><body><sec sec-type="section" id="sec1"><title>1. INTRODUCTORY REMARKS</title><p>The history of microbiologicalresearch has been dominated by investigations of the agents of human infectiousdisease. Motivated by the desire to culture, characterize, and understand thepathogenicity mechanisms of these organisms, several centuries ofmicrobiological research culminated in a broad range of antimicrobialtherapies, vaccines, and immunizations. In more recent years, similaranalytical methodologies have been applied to facilitate exploitation ofbacteria for industrial applications. Two related branches of microbiology&#x02014;environmentalmicrobiology, and the study of intestinal commensals (a branch of the first inpurest terms)&#x02014;lagged behinduntil relatively recently. From the mid 1990s, a range of techniques allowedenvironmental microbiologists to indentify soil microorganisms <italic>in situ</italic>, without resorting toculture, based upon ribosomal small subunit RNA gene probes. A naturalextension of this approach was to sequence large numbers of cloned ribosomalRNA gene amplicons, yielding catalogs of all the organisms (the microbiota)present in complex samples. Latterly the field of metagenomics has providedtechnical approaches to sequence large fractions of the entire microbial DNApresent in an ecological system. Coupled with the application of moleculartools for studying commensal bacteria, many of which were originally developedfor studying pathogens, there is now an exciting nexus between technologies andresearch foci whereby commensal bacteria may be studied in the context ofintestinal ecosystems. This review will summarize what is known about the effectof introducing probiotic bacteria on the composition and activities of the microbiota,with an emphasis on recent studies using culture-independent methods. Thelikely mechanisms whereby commensals  exert their influence are discussed, and directions for future research are outlined.</p></sec><sec sec-type="section" id="sec2"><title>2. THE CONCEPTS OF PROBIOTICS AND PREBIOTICS</title><p>The notion that certain intestinalmicroorganisms might benefit the host derives historically from suggestions by Metchnikoff and others that putrefying bacteria that contribute to toxification and aging could bedeliberately replaced by fermentative organisms [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>]. In this context, some of thefermentative bacteria, Metchnikoff was referring to, are what we now consideras probiotic. Probiotic bacteria are live microorganisms which whenadministered in adequate amount confer a health benefit on the host [<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>]. Many microorganisms that areconsidered probiotic have been traditionally used to preserve food products byfermentation, and are present in the food in varying numbers, along with theirfermentation end products and other metabolites. Thus another operational definitionof the term probiotic requires the organism in question to be &#x0201c;consumed inadequate amounts&#x0201d; to confer a benefit [<xref ref-type="bibr" rid="B5">5</xref>]. The host benefits that havebeen attributed to consumption of probiotic microorganisms are diverse (reviewedin [<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B6">6</xref>&#x02013;<xref ref-type="bibr" rid="B8">8</xref>]; some major examples are listedin <xref ref-type="table" rid="tab1">Table 1</xref>), and have been substantiated to different degrees. Probioticbacteria are now included in a wide range of consumer formulations includingyoghurts, drinks, capsules, and dietary supplements, and they represent asignificant element in the modern functional foods market. Organisms used asprobiotic agents are frequently members of the genera <italic>Lactobacillus</italic> or <italic>Bifidobacterium</italic>,but <italic>Escherichia coli</italic>, <italic>Bacillus subtilis</italic>, <italic>Saccharomyces boulardii,</italic> and <italic>Enterococcus faecium</italic> are also employed, among others [<xref ref-type="bibr" rid="B9">9</xref>]. Thus, an organism employedas a probiotic agent may not necessarily be part of what is considered the&#x0201c;normal microbiota.&#x0201d; Tannock distinguishes between allochthonous andautochthonous species [<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>]. Autochthonous means bacteriaboth present and replicating <italic>in situ</italic> in the human GI tract, as distinct from transiently passing through(allochthonous). Bacteria administered as probiotic agents are not necessarilyautochthonous to the consuming animal, and indeed some <italic>Lactobacillus</italic> species may only be autochthonous for certain humanindividual subjects, and possibly not the majority of subjects (see below). Rate of growth of allochthonous lactobacilli may be a critically limiting steppreventing their establishment [<xref ref-type="bibr" rid="B12">12</xref>]. With regard to developingprobiotic strains for exploitation, it may prove easier to identify beneficialtraits in species that are autochthonous to the human consumer, as consumeracceptance is likely to be easier if the probiotic ingredient in a functionalfood (a food product with benefit to the consumer over and above inherentnutrition) was first cultured from humans.</p><p>Related to the consumption of probiotic agents is the notion of dietaryadjustment to stimulate bacterial growth. A prebiotic compound is defined as &#x0201c;anondigestible food ingredient that beneficially affects the host by selectivelystimulating the growth and/or activity of one or a limited number of bacteriain the colon and thus improves host health&#x0201d; [<xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B31">31</xref>]. It follows from this definitionthat the bacteria capable of metabolizing prebiotics should be restricted to asmall number of beneficial species or strains (reviewed in [<xref ref-type="bibr" rid="B32">32</xref>]). In practice, prebiotic compoundsmust also be refractory to host digestive processes, and the combined catabolicactivities of bacteria higher up in the gastrointestinal tract, so thatprebiotic compounds are often oligosaccharides towards which probiotic bacteriaproduce specific hydrolases [<xref ref-type="bibr" rid="B33">33</xref>]. Prebiotics are commonly found in,or extracted from, plant material including fruits, cereal, and vegetables, butare also present in human milk and colostrum [<xref ref-type="bibr" rid="B6">6</xref>]. The best characterized prebioticsinclude inulin, fructooligosaccharide, galactooligosaccharide, xylooligosaccharide,isomaltooligosaccharide, and lactulose (reviewed in [<xref ref-type="bibr" rid="B32">32</xref>]). Unravelling the health benefitsof prebiotics is a challenging task, because these compounds have paralleldirect effects on the host, and potentially on multiple members of themicrobiota. For example, <italic>&#x003b2;</italic>-glucans are unbranched polysaccharides with (1-4)and (1-3)-linked <italic>&#x003b2;</italic>-D glucopyranosyl units, that are recognized as importantdietary ingredients (reviewed in [<xref ref-type="bibr" rid="B34">34</xref>]). <italic>&#x003b2;</italic>-glucans are components of plantcell walls, and are abundant in the endosperm of cereals such as barley andoatmeal. Consumption of <italic>&#x003b2;</italic>-glucans has attendant health benefits that arerecognized by health and regulatory bodies in several jurisdictions includingthe US  [<xref ref-type="bibr" rid="B35">35</xref>]. These benefits include lowering ofblood cholesterol and lipoprotein [<xref ref-type="bibr" rid="B36">36</xref>], lowering of postprandial glucoseand insulin responses [<xref ref-type="bibr" rid="B37">37</xref>], and enhancement of antitumormonoclonal antibodies [<xref ref-type="bibr" rid="B38">38</xref>]. Supplementation of mammalian dietwith <italic>&#x003b2;</italic>-glucan, or modification by prehydrolysis of <italic>in vitro</italic> bacterial growthmedium, leads to increasednumbers and proportions of lactobacilli or bifidobacteria [<xref ref-type="bibr" rid="B39">39</xref>&#x02013;<xref ref-type="bibr" rid="B41">41</xref>]. Furthermore, <italic>&#x003b2;</italic>-gluco-oligomerspromoted the growth of <italic>L. rhamnosus</italic> GG [<xref ref-type="bibr" rid="B40">40</xref>]. Barley supplementation of ratdiet [<xref ref-type="bibr" rid="B39">39</xref>] led to an increase in <italic>Lactobacillus</italic> numbers, a decrease in <italic>Bacteroides</italic> and coliforms, and an increase in the productionof butyrate. Butyrate is an important energy source, signalling metabolite, proliferationstimulus for normal colonic epithelial cells, and anti-proliferative signal forneoplastic colonocytes [<xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B43">43</xref>], suggesting a potential directbenefit from dietary ingredients or prebiotics that promote growth ofclostridia.</p></sec><sec sec-type="section" id="sec3"><title>3. THE NORMAL MICROBIOTA OFHUMANS AND ANIMALS</title><p>Until recently, the composition of the microbiota was examined byrelatively insensitive techniques. Culturing the bacteria was unrepresentative,because a large proportion of the bacteria do not grow on standard laboratorymedia [<xref ref-type="bibr" rid="B44">44</xref>]. Analysis by temperature gradientgel electrophoresis provided one of the earliest insights into the unchartedcomplexity of the microbiota [<xref ref-type="bibr" rid="B45">45</xref>]. Using denaturing gradient gelelectrophoresis (DGGE) of 16S rRNA gene amplicons, the same group later showedthat the colonic mucosal microbiota and faecal microbiota were different, andthe colonic mucosal microbiota was likely dependent on host factors [<xref ref-type="bibr" rid="B46">46</xref>]. Meanwhile fluorescenthybridization of probes for 16S rRNA genes was being applied to determinespecies identities, numbers, and proportions of intestinal bacteria [<xref ref-type="bibr" rid="B47">47</xref>, <xref ref-type="bibr" rid="B48">48</xref>], exemplified by the studies ofDore, Blaut and colleagues [<xref ref-type="bibr" rid="B49">49</xref>, <xref ref-type="bibr" rid="B50">50</xref>]. These analyses highlightedextensive inter-individual variation at phylotypes level (among northernEuropeans) [<xref ref-type="bibr" rid="B49">49</xref>], and some correlations of microbiotawith age, gender, and geographic origin but which varied between countries [<xref ref-type="bibr" rid="B50">50</xref>].</p><p>Our current understanding of the intestinalmicrobiota (reviewed in [<xref ref-type="bibr" rid="B51">51</xref>, <xref ref-type="bibr" rid="B52">52</xref>]) has been significantly shaped byculture-independent methods, in particular the sequencing of 16S rRNA gene amplicons,either from clone libraries or direct pyrosequencing of the PCR product. Aconsensus appears to be emerging in the literature of somewhere between 800 and1000 bacterial phylotypes being present in the healthy human intestine [<xref ref-type="bibr" rid="B52">52</xref>]; the evidence for which will beselectively presented here. A relatively small-scale investigation by Benno and colleagues in 2003revealed an unexpectedly high number of novel phylotypes in 240 partiallysequenced 16S rRNA gene amplicons clones derived from six elderly individuals [<xref ref-type="bibr" rid="B53">53</xref>]. In a pioneering study, Relmanand colleagues applied the 16S rRNA molecular inventory-based approach, at amuch larger scale than previously published, on samples from both colonic sitesand faeces [<xref ref-type="bibr" rid="B54">54</xref>]; strikingly, the majority of thesequences derivedcorresponded to uncultivated species and novel microorganisms. The humanstomach, previously considered sterile except for infections with <italic>Helicobacter pylori</italic>, was revealed by 16SrRNA gene library sequencing to be well populated by bacteria, based ondetection of 128 bacterial phylotypes from 23 gastric endoscopy samples [<xref ref-type="bibr" rid="B55">55</xref>]. Gill and colleagues [<xref ref-type="bibr" rid="B56">56</xref>] sequenced not just 16S rRNA genes,but also randomly cloned bacterial DNA&#x02014;so-called <italic>metagenomics</italic>, a concept developed forenvironmental community analysis [<xref ref-type="bibr" rid="B57">57</xref>]. Gill et al. showed by this metagenomic approach that the bacteria inthe gut significantly expand the metabolic capabilities of the human gut [<xref ref-type="bibr" rid="B56">56</xref>]. By generating two to three 454pyrosequencing runs per mouse cecum, Gordon and colleagues showed the existenceof an obesity-associated gut microbiome with increased capacity for energyharvest [<xref ref-type="bibr" rid="B58">58</xref>]. Significantly, this balance of themicrobiota was borne out when investigating obese humans [<xref ref-type="bibr" rid="B59">59</xref>], showing a seminal link betweenhuman obesity and changes in the microbiota. Furthermore, the complexity of themicrobiota in humans and 59 other mammalian species was shown to be linked tophylogeny (of the mammal) and the composition of the diet [<xref ref-type="bibr" rid="B60">60</xref>]. Analysis of the metaboliccapability likely conferred by the microbial metagenome recently revealed 237gene families commonly enriched in adult-type and 136 families in infant-typemicrobiomes [<xref ref-type="bibr" rid="B61">61</xref>]. Thus, any consideration of theeffect of probiotics on the intestinal metagenome should ultimately includeanalysis of the downstream effects upon the host of impacting on this metaboliccapability. A more fundamental consideration is that the genera whose membersare among the most commonly employed probiotics&#x02014;<italic>Bifidobacterium</italic> and <italic>Lactobacillus</italic>&#x02014;are not presentin the human gastrointestine at the high levels traditionally expected based onculture-based approaches, being represented by 20 phylotypes (ca. 2%) and 36phylotypes (ca. 3.6%), respectively [<xref ref-type="bibr" rid="B52">52</xref>]. Thus if probiotic bacteria imparthealth benefits to the host under &#x0201c;natural conditions,&#x0201d; that is, inindividuals who have normal nonmanipulated numbers of probiotic bacteria, they accomplishthis despite being at much lower numbers than are achieved by consumption ofprobiotic products.</p></sec><sec sec-type="section" id="sec4"><title>4. PROBIOTICS AND THEIR EFFECTUPON THE MICROBIOTA</title><p>There have been relatively fewstudies which have rigorously characterized the effect upon the whole microbiotaof administering probiotic cultures, and until recently, all such studiesapplied targeted analysis of specific groups of bacteria. In one of theearliest investigations, Tannock and colleagues observed transient and modestfluctuations in lactobacillus and bifidobacterium numbers following consumptionof a probiotic <italic>L. rhamnosus</italic> strainDR20 [<xref ref-type="bibr" rid="B62">62</xref>]. Lactobacilli and enterococciwere detected more frequently (among 10 subjects) and in higher numbers duringconsumption. Interestingly, the presence of stable populations of lactobacillibefore the administration period precluded long-term colonization by theadministered probiotic strain [<xref ref-type="bibr" rid="B62">62</xref>]. Most subjects ceasedshedding the probiotic strain in faeces soon after its consumption stopped, butthe <italic>L. rhamnosus</italic> strain remaineddetectable in faeces of one subject over 2 months after the test period. Thesedata suggest inter-host variables such as bacterium-host or bacterium-dietinteractions.</p><p>Probioticsand prebiotics are commonly applied in companion animals and production animals[<xref ref-type="bibr" rid="B63">63</xref>, <xref ref-type="bibr" rid="B64">64</xref>], and there have been somestudies of effects upon the microbiota. Administration of a cocktail containinglactobacilli, bifidobacteria, enterococci, and pediococci improved weight gainin broiler chickens, which was associated with an increase in numbers of <italic>Bifidobacterium</italic> spp., <italic>Lactobacilli</italic>, and Gram-positive cocci [<xref ref-type="bibr" rid="B65">65</xref>]. Administration of aprobiotic <italic>Enterococcus faecium</italic> strainreduced <italic>E. faecalis</italic> numbers in theintestines of weanling piglets, but total numbers of <italic>E. faecium</italic> remained unchanged, suggesting that the administeredstrain had displaced part of a fixed number of niche sites occupied by the samespecies [<xref ref-type="bibr" rid="B66">66</xref>]. Many investigations havebeen published describing the effects of probiotic bacteria on human pathogens(reviewed in [<xref ref-type="bibr" rid="B67">67</xref>]), some of which are normalcomponents of production animal microbiota. Enterobacteriaceae numbers were reducedwhen a cocktail of two <italic>Lactobacillus</italic> strains was administered to pigs [<xref ref-type="bibr" rid="B68">68</xref>], and a five-strain probioticcombination reduced <italic>Salmonella enterica</italic> serovar Typhimurium shedding inpigs [<xref ref-type="bibr" rid="B69">69</xref>]. Although data from smallanimal models for human probiotic strains must be interpreted with caution [<xref ref-type="bibr" rid="B70">70</xref>], it was interesting to notefrom a recent study that administration of <italic>L. casei</italic> and <italic>L. plantarum</italic> affectedthe diversity of murine intestinal lactobacilli, but not the overall bacterialcommunity structure [<xref ref-type="bibr" rid="B71">71</xref>]. There was an increase in thenumber of lactobacilli related to the <italic>acidophilus</italic> complex in the inoculated mice. These animal models provide an opportunity fordetermining the effect of probiotic administration on the entire microbiota butmust ultimately be repeated in humans if that species is the desired host.</p><p>Studiesin humans are currently few in number, and are often focused in nature. Forexample, consumption of a commercial probiotic yoghurt reduced <italic>Clostridium difficile</italic>-related diarrhoeain hospitalized patients, but effects on the broader microbiota were notstudied [<xref ref-type="bibr" rid="B18">18</xref>]. Alterations in the fecalmicrobiota have been reported in irritable bowel syndrome (IBS) [<xref ref-type="bibr" rid="B72">72</xref>, <xref ref-type="bibr" rid="B73">73</xref>]. However, administration of amultispecies probiotic supplementation which alleviated IBS had negligible effectupon the composition of microbiota as measured by quantitative PCR withgroup-specific primers [<xref ref-type="bibr" rid="B74">74</xref>]. However, this approach mayhave missed changes in microbial composition within these groups. A follow-upstudy reported stabilization of the microbiota over time [<xref ref-type="bibr" rid="B75">75</xref>], which was related toamelioration of symptomatology that was absent from the placebo control group. Alterations of the human intestinal microbiota have also been reported ininflammatory bowel disease (IBD) [<xref ref-type="bibr" rid="B76">76</xref>&#x02013;<xref ref-type="bibr" rid="B78">78</xref>]. Given the clinical impetusto find simple non-medicinal solutions to IBD and IBS, one can anticipaterenewed vigor in studies of probiotic bacteria as agents for microbiotamodulation in these subjects. Probiotics also appear to be efficacious asadjunct therapy for infectious diarrhea, with a recent meta-analysis revealingreduction in risk and duration of diarrhea [<xref ref-type="bibr" rid="B79">79</xref>]. Most of the 23 studiesincluded in this analysis were descriptive rather than investigative of themicrobiological aspects, and future determination of the effects on themicrobiota wrought by probiotic intervention will be very informative. Asrecently as 2006, the effect of probiotic administration in humans was stillbeing followed by bacteriological culture, but as concluded by the authors ofone such study, there was a clear case for culture-independent molecularmethods to be applied instead [<xref ref-type="bibr" rid="B80">80</xref>]. Community profiling by DGGEshowed that lactulose increased the levels of <italic>Bifidobacterium adolescentis</italic> in subjects consuming the prebioticlactulose, whereas the probiotic yeast <italic>S. boulardii</italic> did not cause any significant universal changes in DGGE profiles [<xref ref-type="bibr" rid="B81">81</xref>].</p></sec><sec sec-type="section" id="sec5"><title>5. MECHANISMS OF PROBIOTIC IMPACT ONTHE MICROBIOTA</title><p>				<xref ref-type="fig" rid="fig1">Figure 1</xref> shows aschematic overview of the potential mechanisms whereby probioticmicro-organisms might influence the intestinal microbiota. Consumption of probiotic cultures may modulatethe microbiota or change its metabolic properties by competition for nutritionalsubstrates. Gordon and colleagues have used transcriptional microarrays to showthat introducing a probiotic into the mouse gut changes the way the endogenous microbiotametabolize the diet [<xref ref-type="bibr" rid="B82">82</xref>]. When germ-free mice that had beenmonoassociated with <italic>Bacteroidesthetaiotaomicron</italic> were challenged with <italic>Bifidobacteriumanimalis</italic> or <italic>Lactobacilluscasei</italic>, both interventions caused shifts in the gene expression pattern ofthe <italic>B. thetaiotaomicron</italic> genome [<xref ref-type="bibr" rid="B82">82</xref>]. These differentiallyexpressed gene sets (i.e., in response to the two probiotics) did not overlap,emphasizing that different probiotics elicit different responses. However, manyof the genes in <italic>B. thetaiotaomicron</italic> whose expressionwas altered by presence of either probiotic strain were related to expansion ofthe carbohydrate metabolizing capability of <italic>B. thetaiotaomicron</italic>. Thus, one of the ways in whichprobiotics can impact upon the composition of the microbiota is apparently bycompeting with them for substrate availability, and by altering the dynamics ofcarbohydrate utilization by individual microbiota components. This competitionis probably not restricted to the intestine, since recent evidence indicatesthat oral Bifidobacterium strains (<italic>B. adolescentis</italic>) reduce vitamin K concentration, and may thus compete with <italic>Porphyromonas gingivalis</italic> in theoral cavity [<xref ref-type="bibr" rid="B83">83</xref>].</p><p>The application ofmetabolic profiling methods to animal models has suggested another indirect wayin which probiotic bacteria might impact on the microbiota, namely, byproduction of a significantly different microenvironment due to a diverse rangeof metabolic pathway outcomes. In a recent study using germ-free mice colonizedby human baby microbiota and exposed to two lactobacillus strains, Nicholsonand colleagues observed microbiome modification, measured by selected culture regimes[<xref ref-type="bibr" rid="B84">84</xref>]. This was accompanied bychanges in cecal concentrations of short-chain fatty acids, and marked changesin fecal levels of diverse metabolites including choline, acetate, ethanol, arange of putative N-acetylated metabolites (NAMs), unconjugated bile acids(BAs), and tauro-conjugated bile acids. While a natural focus of these studiesis the effect of these metabolites upon the host [<xref ref-type="bibr" rid="B85">85</xref>], it is likely that such grosschanges in metabolic profile also impact upon intestinal microbiotacomposition. As noted in <xref ref-type="table" rid="tab1">Table 1</xref>, some probiotic bacteria also produce vitamins[<xref ref-type="bibr" rid="B27">27</xref>], enhanced availability ofwhich may modulate the microbiota. In addition, exopolysaccharide produced byprobiotics including lactic acid bacteria [<xref ref-type="bibr" rid="B86">86</xref>] could act as a growthsubstrate for selected components of the microbiota (see <xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><p>Probiotic bacteriaprobably also impact on the general microbiota by direct antagonism. It hasbeen shown in several recent studies that they can modulate numbers of singlemodel organisms in experimental systems. For example, probiotic <italic>L. salivarius</italic> strains inhibit the growth of <italic>H. pylori </italic><italic>in vitro</italic> in a strain-dependent manner [<xref ref-type="bibr" rid="B17">17</xref>], by mechanisms involvinglactic acid secretion, and another as yet uncharacterized mechanism (K. A. Ryanand P. W. O'Toole, unpublished). Intestinal <italic>L. salivarius</italic> strains are distinguished byproduction of a broad-spectrum bacteriocin Abp118 [<xref ref-type="bibr" rid="B87">87</xref>], but this is not likely tocontribute to antagonism to Gram-negative bacteria like <italic>H. pylori</italic>. However, production of this bacteriocin Abp118 wasidentified as the mechanism whereby <italic>L. salivarius</italic> UCC118 eliminated <italic>Listeria monocytogenes</italic> infection in amurine model, providing the first definitive mechanism for anti-infectiveactivity of a probiotic bacterium invivo [<xref ref-type="bibr" rid="B16">16</xref>]. Interestingly, both thewild-type strain UCC118 and a bacteriocin-negative derivative were equally ableto suppress <italic>Salmonella</italic> Typhimuriuminfection in the mouse model, suggesting that broader antimicrobial effects onthe Gram-negative components of the microbiota may occur. From an opposite perspective,production of a bacteriocin-like substance by vaginal enterococci has beenlinked to reduction in levels of commensal lactobacilli that is linked tovaginosis [<xref ref-type="bibr" rid="B88">88</xref>]. Natural competition betweencommensals and opportunistic pathogens may therefore be mediated by mechanismssuch as bacteriocin production, that can be exploited for using probiotics tomodulate the microbiota. Competitive exclusion (see <xref ref-type="fig" rid="fig1">Figure 1</xref>), whereby adherentprobiotic species occlude access of members of the microbiota to the epithelium[<xref ref-type="bibr" rid="B89">89</xref>, <xref ref-type="bibr" rid="B90">90</xref>], represents another way ofmodulating the microbiota, although strong evidence for this occurring <italic>in vivo</italic> is lacking.</p><p>The most subtleeffects wrought by probiotics on the microbiota are potentially those thatoperate by indirect mechanisms involving the host. Improvement of theintestinal epithelium barrier function [<xref ref-type="bibr" rid="B91">91</xref>] might theoretically, forexample, impact on efficiency of invasion of pathogens, severity of subclinicaltissue damage, and release rates of host-derived micronutrients (see <xref ref-type="fig" rid="fig1">Figure 1</xref>),that could translate into impacts on the microbiota. In an analogous manner,pathological changes in intestinal epithelium might also favor growth ofcertain members of the microbiota, if inflamed or damaged epithelial cellsdifferentially affect the microbiota. It is well established that some probioticscan suppress inflammation by inhibiting proinflammatory cytokine production [<xref ref-type="bibr" rid="B92">92</xref>&#x02013;<xref ref-type="bibr" rid="B94">94</xref>], and although the molecularbasis for this is not currently understood for probiotics, mechanisms andmolecules have recently been identified in commensals and pathogens [<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B95">95</xref>]. Reduction in gutinflammation by probiotics could plausibly alter the gut environmentsufficiently to impact on the microbiota. Furthermore, some probiotic bacteriahave been reported to stimulate the innate immune system both in animal modelsand in elderly subjects [<xref ref-type="bibr" rid="B96">96</xref>, <xref ref-type="bibr" rid="B97">97</xref>], by an unknown mechanism. Administration of probiotic bacteria could thus bolster innate immune activityagainst transient pathogens, or non-commensal elements in the microbiota,leading to subtle changes in long-term overall composition. However, morestudies are required to substantiate the mechanisms in the probiotic-hostinteractions, and to investigate if they do in fact impact on the microbiota.</p></sec><sec sec-type="section" id="sec6"><title>6. KNOWLEDGE GAPS AND CONCLUDING REMARKS</title><p>There has been a rapid recentaccumulation of sequence-based information on the composition of the gutmicrobiota. However, for pragmatic reasons of sample collection facility, thisis largely based on fecal analysis, and the microbiota of the colon and smallintestine will be different from feces. Studies of the small intestine areparticularly warranted because probiotics are proportionally more numerousthere, and may exert significant biological activity at this site.</p><p>There is adequateinformation in the literature to support the hypothesis that administration ofprobiotic cultures in high doses to human subjects will impact on theintestinal microbiota. A comprehensive intervention study, supporting thishypothesis by deep compositional and functional metagenomics approaches, andsupplemented by metabolomics, is not currently available (June 2008). In thishypothetical study, mechanisms whereby changes in the microbiota that were achieved couldbe inferred to a degree by global transcriptional analysis, but definitive linkagesbetween bacterial gene products and effects upon the microbiota could beimpossible to establish because of the regulatory issues surrounding humantrials with genetically modified organisms. As noted above, proof of principlemay be established in animal models, but ultimately these studies must bevalidated in human subjects. There remains the intriguing question of the role,if any, of the relatively small numbers of potentially probiotic organisms aspart of the microbiota in ostensibly healthy individuals. Do these organismscontribute to maintenance of health&#x02014;or avoidance ofdisease? Is the level of candidate probiotic organisms in the microbiotacritical, and does its importance vary with age? As noted above, there isreasonable evidence that changes in the microbiota accompany disease stateslike IBD and IBS, conditions whose prevalence increases with aging. There are attractivehygiene-related hypotheses suggesting that depletion of probiotic commensal microbiotain early life may be responsible for the dramatic rise in diseases involvingimmune dysregulation [<xref ref-type="bibr" rid="B98">98</xref>]. The challenge now is to rigorouslytackle the interplay of diet, microbiota, and host factors in tractableexperiments that will elucidate the key elements in determining outcomes ofthis interplay, and allow its manipulation.</p></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>PWOT's Laboratory is supported by the (Government of Ireland)Department of Agriculture Fisheries and Food FHRI award to the ELDERMETproject, and by a CSET award from Science Foundation Ireland to the Alimentary Pharmabiotic Centre. J. C. Cooney is supported by Science Foundation Ireland grant though the Research Frontiers Programme. The authors thank J. Marchesi for critical reading of the manuscript, and K. Nally for helpful discussions.</p></ack><ref-list><ref id="B1"><label>1</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Metchnikoff</surname><given-names>E</given-names></name></person-group><source><italic>The Prolongation of Life: Optimistic Studies</italic></source><year>1907</year><publisher-loc>London, UK</publisher-loc><publisher-name>William Heinemann</publisher-name></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Metchnikoff</surname><given-names>E</given-names></name></person-group><source><italic>The Nature of Man: Studies in Optimistic Philosophy</italic></source><year>1908</year><publisher-loc>London, UK</publisher-loc><publisher-name>William Heinemann</publisher-name></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="other"><collab>FAO/WHO</collab><article-title>Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria</article-title><comment>October 2001, Cordoba, Argentina. Report of a joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria, <ext-link ext-link-type="uri" xlink:href="http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf">http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf</ext-link>.</comment></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuller</surname><given-names>R</given-names></name></person-group><article-title>Probiotics in man and animals</article-title><source><italic>Journal of Applied Bacteriology</italic></source><year>1989</year><volume>66</volume><issue>5</issue><fpage>365</fpage><lpage>378</lpage><pub-id pub-id-type="pmid">2666378</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guarner</surname><given-names>F</given-names></name><name><surname>Schaafsma</surname><given-names>GJ</given-names></name></person-group><article-title>Probiotics</article-title><source><italic>International Journal of Food Microbiology</italic></source><year>1998</year><volume>39</volume><issue>3</issue><fpage>237</fpage><lpage>238</lpage><pub-id pub-id-type="pmid">9553803</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Tannock</surname><given-names>GW</given-names></name></person-group><source><italic>Probiotics and Prebiotics: Scientific Aspects</italic></source><year>2005</year><publisher-loc>Norfolk, UK</publisher-loc><publisher-name>Caister Academic Press</publisher-name></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salminen</surname><given-names>S</given-names></name><name><surname>Bouley</surname><given-names>C</given-names></name><name><surname>Boutron-Ruault</surname><given-names>M-C</given-names></name><etal/></person-group><article-title>Functional food science and gastrointestinal physiology and function</article-title><source><italic>British Journal of Nutrition</italic></source><year>1998</year><volume>80</volume><issue>supplement 1</issue><fpage>S147</fpage><lpage>S171</lpage><pub-id pub-id-type="pmid">9849357</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hord</surname><given-names>NG</given-names></name></person-group><article-title>Eukaryotic-microbiota crosstalk: potential mechanisms for health benefits of prebiotics and probiotics</article-title><source><italic>Annual Review of Nutrition</italic></source><year>2008</year><volume>28</volume><fpage>215</fpage><lpage>231</lpage></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Sullivan</surname><given-names>MG</given-names></name><name><surname>Thorton</surname><given-names>G</given-names></name><name><surname>O'Sullivan</surname><given-names>GC</given-names></name><name><surname>Collins</surname><given-names>JK</given-names></name></person-group><article-title>Probiotic bacteria: myth or reality?</article-title><source><italic>Trends in Food Science &#x00026; Technology</italic></source><year>1992</year><volume>3</volume><fpage>309</fpage><lpage>314</lpage></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Tannock</surname><given-names>GW</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Tannock</surname><given-names>GW</given-names></name></person-group><article-title>The tangled bank and gut microbial ecology</article-title><source><italic>Probiotics and Prebiotics: Scientific Aspects</italic></source><year>2005</year><publisher-loc>Norfolk, UK</publisher-loc><publisher-name>Caister Academic Press</publisher-name><fpage>217</fpage><lpage>223</lpage></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moser</surname><given-names>SA</given-names></name><name><surname>Savage</surname><given-names>DC</given-names></name></person-group><article-title>Bile salt hydrolase activity and resistance to toxicity of conjugated bile salts are unrelated properties in lactobacilli</article-title><source><italic>Applied and Environmental Microbiology</italic></source><year>2001</year><volume>67</volume><issue>8</issue><fpage>3476</fpage><lpage>3480</lpage><pub-id pub-id-type="pmid">11472922</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>YK</given-names></name><name><surname>Ho</surname><given-names>PS</given-names></name><name><surname>Low</surname><given-names>CS</given-names></name><name><surname>Arvilommi</surname><given-names>H</given-names></name><name><surname>Salminen</surname><given-names>S</given-names></name></person-group><article-title>Permanent colonization by <italic>Lactobacillus casei</italic> is hindered by the low rate of cell division in mouse gut</article-title><source><italic>Applied and Environmental Microbiology</italic></source><year>2004</year><volume>70</volume><issue>2</issue><fpage>670</fpage><lpage>674</lpage><pub-id pub-id-type="pmid">14766540</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname><given-names>HS</given-names></name><name><surname>Cross</surname><given-names>ML</given-names></name><name><surname>Rutherfurd</surname><given-names>KJ</given-names></name><name><surname>Gopal</surname><given-names>PK</given-names></name></person-group><article-title>Dietary probiotic supplementation to enhance cellular immunity in the elderly</article-title><source><italic>British Journal of Biomedical Science</italic></source><year>2001</year><volume>58</volume><issue>2</issue><fpage>94</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">11440213</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazmanian</surname><given-names>SK</given-names></name><name><surname>Round</surname><given-names>JL</given-names></name><name><surname>Kasper</surname><given-names>DL</given-names></name></person-group><article-title>A microbial symbiosis factor prevents intestinal inflammatory disease</article-title><source><italic>Nature</italic></source><year>2008</year><volume>453</volume><issue>7195</issue><fpage>620</fpage><lpage>625</lpage><pub-id pub-id-type="pmid">18509436</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruas-Madiedo</surname><given-names>P</given-names></name><name><surname>Gueimonde</surname><given-names>M</given-names></name><name><surname>Margolles</surname><given-names>A</given-names></name><name><surname>De Los Reyes-Gavil&#x000e1;n</surname><given-names>CG</given-names></name><name><surname>Salminen</surname><given-names>S</given-names></name></person-group><article-title>Exopolysaccharides produced by probiotic strains modify the adhesion of probiotics and enteropathogens to human intestinal mucus</article-title><source><italic>Journal of Food Protection</italic></source><year>2006</year><volume>69</volume><issue>8</issue><fpage>2011</fpage><lpage>2015</lpage><pub-id pub-id-type="pmid">16924934</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corr</surname><given-names>SC</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Riedel</surname><given-names>CU</given-names></name><name><surname>O'Toole</surname><given-names>PW</given-names></name><name><surname>Hill</surname><given-names>C</given-names></name><name><surname>Gahan</surname><given-names>CGM</given-names></name></person-group><article-title>Bacteriocin production as a mechanism for the antiinfective activity of <italic>Lactobacillus salivarius</italic> UCC118</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2007</year><volume>104</volume><issue>18</issue><fpage>7617</fpage><lpage>7621</lpage><pub-id pub-id-type="pmid">17456596</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryan</surname><given-names>KA</given-names></name><name><surname>Daly</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Hooton</surname><given-names>C</given-names></name><name><surname>O'Toole</surname><given-names>PW</given-names></name></person-group><article-title>Strain-specific inhibition of Helicobacter pylori by <italic>Lactobacillus salivarius</italic> and other lactobacilli</article-title><source><italic>Journal of Antimicrobial Chemotherapy</italic></source><year>2008</year><volume>61</volume><issue>4</issue><fpage>831</fpage><lpage>834</lpage><pub-id pub-id-type="pmid">18263567</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hickson</surname><given-names>M</given-names></name><name><surname>D'Souza</surname><given-names>AL</given-names></name><name><surname>Muthu</surname><given-names>N</given-names></name><etal/></person-group><article-title>Use of probiotic <italic>Lactobacillus</italic> preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial</article-title><source><italic>British Medical Journal</italic></source><year>2007</year><volume>335</volume><issue>7610</issue><fpage>80</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">17604300</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saavedra</surname><given-names>JM</given-names></name><name><surname>Bauman</surname><given-names>NA</given-names></name><name><surname>Oung</surname><given-names>I</given-names></name><name><surname>Perman</surname><given-names>JA</given-names></name><name><surname>Yolken</surname><given-names>RH</given-names></name></person-group><article-title>Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus</article-title><source><italic>The Lancet</italic></source><year>1994</year><volume>344</volume><issue>8929</issue><fpage>1046</fpage><lpage>1049</lpage></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luyer</surname><given-names>MD</given-names></name><name><surname>Buurman</surname><given-names>WA</given-names></name><name><surname>Hadfoune</surname><given-names>M</given-names></name><etal/></person-group><article-title>Strain-specific effects of probiotics on gut barrier integrity following hemorrhagic shock</article-title><source><italic>Infection and Immunity</italic></source><year>2005</year><volume>73</volume><issue>6</issue><fpage>3686</fpage><lpage>3692</lpage><pub-id pub-id-type="pmid">15908398</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capurso</surname><given-names>G</given-names></name><name><surname>Marignani</surname><given-names>M</given-names></name><name><surname>Delle Fave</surname><given-names>G</given-names></name></person-group><article-title>Probiotics and the incidence of colorectal cancer: when evidence is not evident</article-title><source><italic>Digestive and Liver Disease</italic></source><year>2006</year><volume>38</volume><issue>supplement 2</issue><fpage>S277</fpage><lpage>S282</lpage><pub-id pub-id-type="pmid">17259091</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Seto</surname><given-names>D</given-names></name><name><surname>Bielory</surname><given-names>L</given-names></name></person-group><article-title>Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis</article-title><source><italic>Journal of Allergy and Clinical Immunology</italic></source><year>2008</year><volume>121</volume><issue>1</issue><fpage>116</fpage><lpage>121.e11</lpage><pub-id pub-id-type="pmid">18206506</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Smet</surname><given-names>I</given-names></name><name><surname>De Boever</surname><given-names>P</given-names></name><name><surname>Verstraete</surname><given-names>W</given-names></name></person-group><article-title>Cholesterol lowering in pigs through enhanced bacterial bile salt hydrolase activity</article-title><source><italic>British Journal of Nutrition</italic></source><year>1998</year><volume>79</volume><issue>2</issue><fpage>185</fpage><lpage>194</lpage><pub-id pub-id-type="pmid">9536863</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klaver</surname><given-names>FAM</given-names></name><name><surname>van der Meer</surname><given-names>R</given-names></name></person-group><article-title>The assumed assimilation of cholesterol by lactobacilli and <italic>Bifidobacterium bifidum</italic> is due to their bile salt-deconjugating activity</article-title><source><italic>Applied and Environmental Microbiology</italic></source><year>1993</year><volume>59</volume><issue>4</issue><fpage>1120</fpage><lpage>1124</lpage><pub-id pub-id-type="pmid">8489229</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Lindstr&#x000f6;m</surname><given-names>J</given-names></name><name><surname>Hyyrynen</surname><given-names>J</given-names></name><etal/></person-group><article-title>Effect of ingesting sour milk fermented using <italic>Lactobacillus helveticus</italic> bacteria producing tripeptides on blood pressure in subjects with mild hypertension</article-title><source><italic>Journal of Human Hypertension</italic></source><year>2004</year><volume>18</volume><issue>11</issue><fpage>795</fpage><lpage>802</lpage><pub-id pub-id-type="pmid">15175633</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savaiano</surname><given-names>DA</given-names></name><name><surname>AbouElAnouar</surname><given-names>A</given-names></name><name><surname>Smith</surname><given-names>DE</given-names></name><name><surname>Levitt</surname><given-names>MD</given-names></name></person-group><article-title>Lactose malabsorption from yogurt, pasteurized yogurt, sweet acidophilus milk, and cultured milk in lactase-deficient individuals</article-title><source><italic>The American Journal of Clinical Nutrition</italic></source><year>1984</year><volume>40</volume><issue>6</issue><fpage>1219</fpage><lpage>1223</lpage><pub-id pub-id-type="pmid">6439026</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanton</surname><given-names>C</given-names></name><name><surname>Ross</surname><given-names>RP</given-names></name><name><surname>Fitzgerald</surname><given-names>GF</given-names></name><name><surname>Van Sinderen</surname><given-names>D</given-names></name></person-group><article-title>Fermented functional foods based on probiotics and their biogenic metabolites</article-title><source><italic>Current Opinion in Biotechnology</italic></source><year>2005</year><volume>16</volume><issue>2</issue><fpage>198</fpage><lpage>203</lpage><pub-id pub-id-type="pmid">15831387</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Vazquez Roque</surname><given-names>MI</given-names></name><name><surname>Camilleri</surname><given-names>M</given-names></name><etal/></person-group><article-title>A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating</article-title><source><italic>Neurogastroenterology and Motility</italic></source><year>2005</year><volume>17</volume><issue>5</issue><fpage>687</fpage><lpage>696</lpage><pub-id pub-id-type="pmid">16185307</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whorwell</surname><given-names>PJ</given-names></name><name><surname>Altringer</surname><given-names>L</given-names></name><name><surname>Morel</surname><given-names>J</given-names></name><etal/></person-group><article-title>Efficacy of an encapsulated probiotic <italic>Bifidobacterium infantis</italic> 35624 in women with irritable bowel syndrome</article-title><source><italic>The American Journal of Gastroenterology</italic></source><year>2006</year><volume>101</volume><issue>7</issue><fpage>1581</fpage><lpage>1590</lpage><pub-id pub-id-type="pmid">16863564</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibson</surname><given-names>GR</given-names></name><name><surname>Roberfroid</surname><given-names>MB</given-names></name></person-group><article-title>Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics</article-title><source><italic>The Journal of Nutrition</italic></source><year>1995</year><volume>125</volume><issue>6</issue><fpage>1401</fpage><lpage>1412</lpage><pub-id pub-id-type="pmid">7782892</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macfarlane</surname><given-names>S</given-names></name><name><surname>Macfarlane</surname><given-names>GT</given-names></name><name><surname>Cummings</surname><given-names>JH</given-names></name></person-group><article-title>Review article: prebiotics in the gastrointestinal tract</article-title><source><italic>Alimentary Pharmacology &#x00026; Therapeutics</italic></source><year>2006</year><volume>24</volume><issue>5</issue><fpage>701</fpage><lpage>714</lpage><pub-id pub-id-type="pmid">16918875</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Gibson</surname><given-names>GR</given-names></name><name><surname>Rastall</surname><given-names>RA</given-names></name></person-group><source><italic>Prebiotics: Development and Application</italic></source><year>2006</year><publisher-loc>Chicester, UK</publisher-loc><publisher-name>John Wiley &#x00026; sons</publisher-name></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Broek</surname><given-names>LAM</given-names></name><name><surname>Hinz</surname><given-names>SWA</given-names></name><name><surname>Beldman</surname><given-names>G</given-names></name><name><surname>Vincken</surname><given-names>J-P</given-names></name><name><surname>Voragen</surname><given-names>AGJ</given-names></name></person-group><article-title>						<italic>Bifidobacterium</italic> carbohydrases-their role in breakdown and synthesis of (potential) prebiotics</article-title><source><italic>Molecular Nutrition &#x00026; Food Research</italic></source><year>2008</year><volume>52</volume><issue>1</issue><fpage>146</fpage><lpage>163</lpage><pub-id pub-id-type="pmid">18040988</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charalampopoulos</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Pandiella</surname><given-names>SS</given-names></name><name><surname>Webb</surname><given-names>C</given-names></name></person-group><article-title>Application of cereals and cereal components in functional foods: a review</article-title><source><italic>International Journal of Food Microbiology</italic></source><year>2002</year><volume>79</volume><issue>1-2</issue><fpage>131</fpage><lpage>141</lpage><pub-id pub-id-type="pmid">12382693</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><collab>Food and Drug Administration</collab><article-title>Food labeling; health claims; soluble dietary fiber from certain foods and coronary heart disease. Final rule</article-title><source><italic>Federal Register</italic></source><year>2006</year><volume>71</volume><issue>98</issue><fpage>29248</fpage><lpage>29250</lpage><pub-id pub-id-type="pmid">16749215</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braaten</surname><given-names>JT</given-names></name><name><surname>Wood</surname><given-names>PJ</given-names></name><name><surname>Scott</surname><given-names>FW</given-names></name><etal/></person-group><article-title>Oat <italic>&#x003b2;</italic>-glucan reduces blood cholesterol concentration in hypercholesterolemic subjects</article-title><source><italic>European Journal of Clinical Nutrition</italic></source><year>1994</year><volume>48</volume><issue>7</issue><fpage>465</fpage><lpage>474</lpage><pub-id pub-id-type="pmid">7956987</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braaten</surname><given-names>JT</given-names></name><name><surname>Scott</surname><given-names>FW</given-names></name><name><surname>Wood</surname><given-names>PJ</given-names></name><etal/></person-group><article-title>High <italic>&#x003b2;</italic>-glucan oat bran and oat gum reduce postprandial blood glucose and insulin in subjects with and without type 2 diabetes</article-title><source><italic>Diabetic Medicine</italic></source><year>1994</year><volume>11</volume><issue>3</issue><fpage>312</fpage><lpage>318</lpage><pub-id pub-id-type="pmid">8033532</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>WY</given-names></name><name><surname>Hui</surname><given-names>PK</given-names></name><name><surname>Chan</surname><given-names>JKC</given-names></name><etal/></person-group><article-title>Epithelial damage by <italic>Helicobacter pylori</italic> in gastric ulcers</article-title><source><italic>Histopathology</italic></source><year>1991</year><volume>19</volume><issue>1</issue><fpage>47</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">1916686</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dongowski</surname><given-names>G</given-names></name><name><surname>Huth</surname><given-names>M</given-names></name><name><surname>Gebhardt</surname><given-names>E</given-names></name><name><surname>Flamme</surname><given-names>W</given-names></name></person-group><article-title>Dietary fiber-rich barley products beneficially affect the intestinal tract of rats</article-title><source><italic>The Journal of Nutrition</italic></source><year>2002</year><volume>132</volume><issue>12</issue><fpage>3704</fpage><lpage>3714</lpage><pub-id pub-id-type="pmid">12468611</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaskari</surname><given-names>J</given-names></name><name><surname>Kontula</surname><given-names>P</given-names></name><name><surname>Siitonen</surname><given-names>A</given-names></name><name><surname>Jousimies-Somer</surname><given-names>H</given-names></name><name><surname>Mattila-Sandholm</surname><given-names>T</given-names></name><name><surname>Poutanen</surname><given-names>K</given-names></name></person-group><article-title>Oat <italic>&#x003b2;</italic>-glucan and xylan hydrolysates as selective substrates for <italic>Bifidobacterium</italic> and <italic>Lactobacillus</italic> strains</article-title><source><italic>Applied Microbiology and Biotechnology</italic></source><year>1998</year><volume>49</volume><issue>2</issue><fpage>175</fpage><lpage>181</lpage><pub-id pub-id-type="pmid">9534257</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snart</surname><given-names>J</given-names></name><name><surname>Bibiloni</surname><given-names>R</given-names></name><name><surname>Grayson</surname><given-names>T</given-names></name><etal/></person-group><article-title>Supplementation of the diet with high-viscosity beta-glucan results in enrichment for lactobacilli in the rat cecum</article-title><source><italic>Applied and Environmental Microbiology</italic></source><year>2006</year><volume>72</volume><issue>3</issue><fpage>1925</fpage><lpage>1931</lpage><pub-id pub-id-type="pmid">16517639</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Topping</surname><given-names>DL</given-names></name><name><surname>Clifton</surname><given-names>PM</given-names></name></person-group><article-title>Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides</article-title><source><italic>Physiological Reviews</italic></source><year>2001</year><volume>81</volume><issue>3</issue><fpage>1031</fpage><lpage>1064</lpage><pub-id pub-id-type="pmid">11427691</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vel&#x000e1;zquez</surname><given-names>OC</given-names></name><name><surname>Lederer</surname><given-names>HM</given-names></name><name><surname>Rombeau</surname><given-names>JL</given-names></name></person-group><article-title>Butyrate and the colonocyte: implications for neoplasia</article-title><source><italic>Digestive Diseases and Sciences</italic></source><year>1996</year><volume>41</volume><issue>4</issue><fpage>727</fpage><lpage>739</lpage><pub-id pub-id-type="pmid">8674394</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suau</surname><given-names>A</given-names></name><name><surname>Bonnet</surname><given-names>R</given-names></name><name><surname>Sutren</surname><given-names>M</given-names></name><etal/></person-group><article-title>Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut</article-title><source><italic>Applied and Environmental Microbiology</italic></source><year>1999</year><volume>65</volume><issue>11</issue><fpage>4799</fpage><lpage>4807</lpage><pub-id pub-id-type="pmid">10543789</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zoetendal</surname><given-names>EG</given-names></name><name><surname>Akkermans</surname><given-names>ADL</given-names></name><name><surname>de Vos</surname><given-names>WM</given-names></name></person-group><article-title>Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria</article-title><source><italic>Applied and Environmental Microbiology</italic></source><year>1998</year><volume>64</volume><issue>10</issue><fpage>3854</fpage><lpage>3859</lpage><pub-id pub-id-type="pmid">9758810</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zoetendal</surname><given-names>EG</given-names></name><name><surname>Von Wright</surname><given-names>A</given-names></name><name><surname>Vilpponen-Salmela</surname><given-names>T</given-names></name><name><surname>Ben-Amor</surname><given-names>K</given-names></name><name><surname>Akkermans</surname><given-names>ADL</given-names></name><name><surname>de Vos</surname><given-names>WM</given-names></name></person-group><article-title>Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces</article-title><source><italic>Applied and Environmental Microbiology</italic></source><year>2002</year><volume>68</volume><issue>7</issue><fpage>3401</fpage><lpage>3407</lpage><pub-id pub-id-type="pmid">12089021</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaughan</surname><given-names>EE</given-names></name><name><surname>Heilig</surname><given-names>HGHJ</given-names></name><name><surname>Ben-Amor</surname><given-names>K</given-names></name><name><surname>de Vos</surname><given-names>WM</given-names></name></person-group><article-title>Diversity, vitality and activities of intestinal lactic acid bacteria and bifidobacteria assessed by molecular approaches</article-title><source><italic>FEMS Microbiology Reviews</italic></source><year>2005</year><volume>29</volume><issue>3</issue><fpage>477</fpage><lpage>490</lpage><pub-id pub-id-type="pmid">16125009</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaughan</surname><given-names>EE</given-names></name><name><surname>Schut</surname><given-names>F</given-names></name><name><surname>Heilig</surname><given-names>HG</given-names></name><name><surname>Zoetendal</surname><given-names>EG</given-names></name><name><surname>de Vos</surname><given-names>WM</given-names></name><name><surname>Akkermans</surname><given-names>AD</given-names></name></person-group><article-title>A molecular view of the intestinal ecosystem</article-title><source><italic>Current Issues in Intestinal Microbiology</italic></source><year>2000</year><volume>1</volume><issue>1</issue><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">11709849</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lay</surname><given-names>C</given-names></name><name><surname>Rigottier-Gois</surname><given-names>L</given-names></name><name><surname>Holmstr&#x000f8;m</surname><given-names>K</given-names></name><etal/></person-group><article-title>Colonic microbiota signatures across five northern European countries</article-title><source><italic>Applied and Environmental Microbiology</italic></source><year>2005</year><volume>71</volume><issue>7</issue><fpage>4153</fpage><lpage>4155</lpage><pub-id pub-id-type="pmid">16000838</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mueller</surname><given-names>S</given-names></name><name><surname>Saunier</surname><given-names>K</given-names></name><name><surname>Hanisch</surname><given-names>C</given-names></name><etal/></person-group><article-title>Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study</article-title><source><italic>Applied and Environmental Microbiology</italic></source><year>2006</year><volume>72</volume><issue>2</issue><fpage>1027</fpage><lpage>1033</lpage><pub-id pub-id-type="pmid">16461645</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchesi</surname><given-names>J</given-names></name><name><surname>Shanahan</surname><given-names>F</given-names></name></person-group><article-title>The normal intestinal microbiota</article-title><source><italic>Current Opinion in Infectious Diseases</italic></source><year>2007</year><volume>20</volume><issue>5</issue><fpage>508</fpage><lpage>513</lpage><pub-id pub-id-type="pmid">17762785</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajili&#x00107;-Stojanovi&#x00107;</surname><given-names>M</given-names></name><name><surname>Smidt</surname><given-names>H</given-names></name><name><surname>de Vos</surname><given-names>WM</given-names></name></person-group><article-title>Diversity of the human gastrointestinal tract microbiota revisited</article-title><source><italic>Environmental Microbiology</italic></source><year>2007</year><volume>9</volume><issue>9</issue><fpage>2125</fpage><lpage>2136</lpage><pub-id pub-id-type="pmid">17686012</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>H</given-names></name><name><surname>Sakamoto</surname><given-names>M</given-names></name><name><surname>Kitahara</surname><given-names>M</given-names></name><name><surname>Benno</surname><given-names>Y</given-names></name></person-group><article-title>Molecular analysis of fecal microbiota in elderly individuals using 16S rDNA library and T-RFLP</article-title><source><italic>Microbiology and Immunology</italic></source><year>2003</year><volume>47</volume><issue>8</issue><fpage>557</fpage><lpage>570</lpage><pub-id pub-id-type="pmid">14524616</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eckburg</surname><given-names>PB</given-names></name><name><surname>Bik</surname><given-names>EM</given-names></name><name><surname>Bernstein</surname><given-names>CN</given-names></name><etal/></person-group><article-title>Diversity of the human intestinal microbial flora</article-title><source><italic>Science</italic></source><year>2005</year><volume>308</volume><issue>5728</issue><fpage>1635</fpage><lpage>1638</lpage><pub-id pub-id-type="pmid">15831718</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bik</surname><given-names>EM</given-names></name><name><surname>Eckburg</surname><given-names>PB</given-names></name><name><surname>Gill</surname><given-names>SR</given-names></name><etal/></person-group><article-title>Molecular analysis of the bacterial microbiota in the human stomach</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2006</year><volume>103</volume><issue>3</issue><fpage>732</fpage><lpage>737</lpage><pub-id pub-id-type="pmid">16407106</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname><given-names>SR</given-names></name><name><surname>Pop</surname><given-names>M</given-names></name><name><surname>DeBoy</surname><given-names>RT</given-names></name><etal/></person-group><article-title>Metagenomic analysis of the human distal gut microbiome</article-title><source><italic>Science</italic></source><year>2006</year><volume>312</volume><issue>5778</issue><fpage>1355</fpage><lpage>1359</lpage><pub-id pub-id-type="pmid">16741115</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Handelsman</surname><given-names>J</given-names></name></person-group><article-title>Metagenomics: application of genomics to uncultured microorganisms</article-title><source><italic>Microbiology and Molecular Biology Reviews</italic></source><year>2004</year><volume>68</volume><issue>4</issue><fpage>669</fpage><lpage>685</lpage><pub-id pub-id-type="pmid">15590779</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turnbaugh</surname><given-names>PJ</given-names></name><name><surname>Ley</surname><given-names>RE</given-names></name><name><surname>Mahowald</surname><given-names>MA</given-names></name><name><surname>Magrini</surname><given-names>V</given-names></name><name><surname>Mardis</surname><given-names>ER</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name></person-group><article-title>An obesity-associated gut microbiome with increased capacity for energy harvest</article-title><source><italic>Nature</italic></source><year>2006</year><volume>444</volume><issue>7122</issue><fpage>1027</fpage><lpage>1031</lpage><pub-id pub-id-type="pmid">17183312</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ley</surname><given-names>RE</given-names></name><name><surname>Turnbaugh</surname><given-names>PJ</given-names></name><name><surname>Klein</surname><given-names>S</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name></person-group><article-title>Microbial ecology: human gut microbes associated with obesity</article-title><source><italic>Nature</italic></source><year>2006</year><volume>444</volume><issue>7122</issue><fpage>1022</fpage><lpage>1023</lpage><pub-id pub-id-type="pmid">17183309</pub-id></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ley</surname><given-names>RE</given-names></name><name><surname>Hamady</surname><given-names>M</given-names></name><name><surname>Lozupone</surname><given-names>C</given-names></name><etal/></person-group><article-title>Evolution of mammals and their gut microbes</article-title><source><italic>Science</italic></source><year>2008</year><volume>320</volume><issue>5883</issue><fpage>1647</fpage><lpage>1651</lpage><pub-id pub-id-type="pmid">18497261</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurokawa</surname><given-names>K</given-names></name><name><surname>Itoh</surname><given-names>T</given-names></name><name><surname>Kuwahara</surname><given-names>T</given-names></name><etal/></person-group><article-title>Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes</article-title><source><italic>DNA Research</italic></source><year>2007</year><volume>14</volume><issue>4</issue><fpage>169</fpage><lpage>181</lpage><pub-id pub-id-type="pmid">17916580</pub-id></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tannock</surname><given-names>GW</given-names></name><name><surname>Munro</surname><given-names>K</given-names></name><name><surname>Harmsen</surname><given-names>HJM</given-names></name><name><surname>Welling</surname><given-names>GW</given-names></name><name><surname>Smart</surname><given-names>J</given-names></name><name><surname>Gopal</surname><given-names>PK</given-names></name></person-group><article-title>Analysis of the fecal microflora of human subjects consuming a probiotic product containing <italic>Lactobacillus rhamnosus</italic> DR20</article-title><source><italic>Applied and Environmental Microbiology</italic></source><year>2000</year><volume>66</volume><issue>6</issue><fpage>2578</fpage><lpage>2588</lpage><pub-id pub-id-type="pmid">10831441</pub-id></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patterson</surname><given-names>JA</given-names></name><name><surname>Burkholder</surname><given-names>KM</given-names></name></person-group><article-title>Application of prebiotics and probiotics in poultry production</article-title><source><italic>Poultry Science</italic></source><year>2003</year><volume>82</volume><issue>4</issue><fpage>627</fpage><lpage>631</lpage></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Swanson</surname><given-names>KS</given-names></name><name><surname>Fahey</surname><given-names>GJ</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Gibson</surname><given-names>GR</given-names></name><name><surname>Rastall</surname><given-names>RA</given-names></name></person-group><article-title>Prebiotic impacts on companion animals</article-title><source><italic>Prebiotics: Development and Applications</italic></source><year>2006</year><publisher-loc>Chicester, UK</publisher-loc><publisher-name>John Wiley &#x00026; sons</publisher-name><fpage>213</fpage><lpage>236</lpage></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mountzouris</surname><given-names>KC</given-names></name><name><surname>Tsirtsikos</surname><given-names>P</given-names></name><name><surname>Kalamara</surname><given-names>E</given-names></name><name><surname>Nitsch</surname><given-names>S</given-names></name><name><surname>Schatzmayr</surname><given-names>G</given-names></name><name><surname>Fegeros</surname><given-names>K</given-names></name></person-group><article-title>Evaluation of the efficacy of a probiotic containing <italic>Lactobacillus</italic>, <italic>Bifidobacterium</italic>, <italic>Enterococcus</italic>, and <italic>Pediococcus</italic> strains in promoting broiler performance and modulating cecal microflora composition and metabolic activities</article-title><source><italic>Poultry Science</italic></source><year>2007</year><volume>86</volume><issue>2</issue><fpage>309</fpage><lpage>317</lpage></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vahjen</surname><given-names>W</given-names></name><name><surname>Taras</surname><given-names>D</given-names></name><name><surname>Simon</surname><given-names>O</given-names></name></person-group><article-title>Effect of the probiotic <italic>Enterococcus faecium</italic> NCIMB10415 on cell numbers of total <italic>Enterococcus</italic> spp., <italic>E. faecium</italic> and <italic>E. faecalis</italic> in the intestine of piglets</article-title><source><italic>Current Issues in Intestinal Microbiology</italic></source><year>2007</year><volume>8</volume><issue>1</issue><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">17489433</pub-id></element-citation></ref><ref id="B67"><label>67</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Walter</surname><given-names>J</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Tannock</surname><given-names>GW</given-names></name></person-group><article-title>The microecology of Lactobacilli in the gastrointestinal tract</article-title><source><italic>Probiotics and Prebiotics: Scientific Aspects</italic></source><year>2005</year><publisher-loc>Norfolk, UK</publisher-loc><publisher-name>Caister Academic Press</publisher-name><fpage>51</fpage><lpage>82</lpage></element-citation></ref><ref id="B68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardiner</surname><given-names>GE</given-names></name><name><surname>Casey</surname><given-names>PG</given-names></name><name><surname>Casey</surname><given-names>G</given-names></name><etal/></person-group><article-title>Relative ability of orally administered <italic>Lactobacillus murinus</italic> to predominate and persist in the porcine gastrointestinal tract</article-title><source><italic>Applied and Environmental Microbiology</italic></source><year>2004</year><volume>70</volume><issue>4</issue><fpage>1895</fpage><lpage>1906</lpage><pub-id pub-id-type="pmid">15066778</pub-id></element-citation></ref><ref id="B69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casey</surname><given-names>PG</given-names></name><name><surname>Gardiner</surname><given-names>GE</given-names></name><name><surname>Casey</surname><given-names>G</given-names></name><etal/></person-group><article-title>A five-strain probiotic combination reduces pathogen shedding and alleviates disease signs in pigs challenged with <italic>Salmonella enterica</italic> serovar typhimurium</article-title><source><italic>Applied and Environmental Microbiology</italic></source><year>2007</year><volume>73</volume><issue>6</issue><fpage>1858</fpage><lpage>1863</lpage><pub-id pub-id-type="pmid">17261517</pub-id></element-citation></ref><ref id="B70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pavan</surname><given-names>S</given-names></name><name><surname>Desreumaux</surname><given-names>P</given-names></name><name><surname>Mercenier</surname><given-names>A</given-names></name></person-group><article-title>Use of mouse models to evaluate the persistence, safety, and immune modulation capacities of lactic acid bacteria</article-title><source><italic>Clinical and Diagnostic Laboratory Immunology</italic></source><year>2003</year><volume>10</volume><issue>4</issue><fpage>696</fpage><lpage>701</lpage><pub-id pub-id-type="pmid">12853407</pub-id></element-citation></ref><ref id="B71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuentes</surname><given-names>S</given-names></name><name><surname>Egert</surname><given-names>M</given-names></name><name><surname>Jim&#x000e9;nez-Valera</surname><given-names>M</given-names></name><etal/></person-group><article-title>Administration of <italic>Lactobacillus casei</italic> and <italic>Lactobacillus plantarum</italic> affects the diversity of murine intestinal lactobacilli, but not the overall bacterial community structure</article-title><source><italic>Research in Microbiology</italic></source><year>2008</year><volume>159</volume><issue>4</issue><fpage>237</fpage><lpage>243</lpage><pub-id pub-id-type="pmid">18439805</pub-id></element-citation></ref><ref id="B72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kassinen</surname><given-names>A</given-names></name><name><surname>Krogius-Kurikka</surname><given-names>L</given-names></name><name><surname>M&#x000e4;kivuokko</surname><given-names>H</given-names></name><etal/></person-group><article-title>The fecal microbiota of irritable bowel syndrome patients differssignificantly from that of healthy subjects</article-title><source><italic>Gastroenterology</italic></source><year>2007</year><volume>133</volume><issue>1</issue><fpage>24</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">17631127</pub-id></element-citation></ref><ref id="B73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satokari</surname><given-names>RM</given-names></name><name><surname>Vaughan</surname><given-names>EE</given-names></name><name><surname>Smidt</surname><given-names>H</given-names></name><name><surname>Saarela</surname><given-names>M</given-names></name><name><surname>M&#x000e4;tt&#x000f6;</surname><given-names>J</given-names></name><name><surname>de Vos</surname><given-names>WM</given-names></name></person-group><article-title>Molecular approaches for the detection and identification of bifidobacteria and lactobacilli in the human gastrointestinal tract</article-title><source><italic>Systematic and Applied Microbiology</italic></source><year>2003</year><volume>26</volume><issue>4</issue><fpage>572</fpage><lpage>584</lpage><pub-id pub-id-type="pmid">14666986</pub-id></element-citation></ref><ref id="B74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kajander</surname><given-names>K</given-names></name><name><surname>Krogius-Kurikka</surname><given-names>L</given-names></name><name><surname>Rinttil&#x000e4;</surname><given-names>T</given-names></name><name><surname>Karjalainen</surname><given-names>H</given-names></name><name><surname>Palva</surname><given-names>A</given-names></name><name><surname>Korpela</surname><given-names>R</given-names></name></person-group><article-title>Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome</article-title><source><italic>Alimentary Pharmacology &#x00026; Therapeutics</italic></source><year>2007</year><volume>26</volume><issue>3</issue><fpage>463</fpage><lpage>473</lpage><pub-id pub-id-type="pmid">17635381</pub-id></element-citation></ref><ref id="B75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kajander</surname><given-names>K</given-names></name><name><surname>Myllyluoma</surname><given-names>E</given-names></name><name><surname>Rajili&#x00107;-Stojanovi&#x00107;</surname><given-names>M</given-names></name><etal/></person-group><article-title>Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota</article-title><source><italic>Alimentary Pharmacology &#x00026; Therapeutics</italic></source><year>2008</year><volume>27</volume><issue>1</issue><fpage>48</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">17919270</pub-id></element-citation></ref><ref id="B76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname><given-names>DN</given-names></name><name><surname>St. Amand</surname><given-names>AL</given-names></name><name><surname>Feldman</surname><given-names>RA</given-names></name><name><surname>Boedeker</surname><given-names>EC</given-names></name><name><surname>Harpaz</surname><given-names>N</given-names></name><name><surname>Pace</surname><given-names>NR</given-names></name></person-group><article-title>Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2007</year><volume>104</volume><issue>34</issue><fpage>13780</fpage><lpage>13785</lpage><pub-id pub-id-type="pmid">17699621</pub-id></element-citation></ref><ref id="B77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manichanh</surname><given-names>C</given-names></name><name><surname>Rigottier-Gois</surname><given-names>L</given-names></name><name><surname>Bonnaud</surname><given-names>E</given-names></name><etal/></person-group><article-title>Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach</article-title><source><italic>Gut</italic></source><year>2006</year><volume>55</volume><issue>2</issue><fpage>205</fpage><lpage>211</lpage><pub-id pub-id-type="pmid">16188921</pub-id></element-citation></ref><ref id="B78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scanlan</surname><given-names>PD</given-names></name><name><surname>Shanahan</surname><given-names>F</given-names></name><name><surname>Marchesi</surname><given-names>JR</given-names></name></person-group><article-title>Human methanogen diversity and incidence in healthy and diseased colonic groups using mcrA gene analysis</article-title><source><italic>BMC Microbiology</italic></source><year>2008</year><volume>8, article 79</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">18173832</pub-id></element-citation></ref><ref id="B79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>SJ</given-names></name><name><surname>Okoko</surname><given-names>B</given-names></name><name><surname>Martinez</surname><given-names>E</given-names></name><name><surname>Gregorio</surname><given-names>G</given-names></name><name><surname>Dans</surname><given-names>LF</given-names></name></person-group><article-title>Probiotics for treating infectious diarrhoea</article-title><source><italic>Cochrane Database of Systematic Reviews</italic></source><year>2004</year><issue>2</issue><comment>Article ID CD003048.</comment></element-citation></ref><ref id="B80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goossens</surname><given-names>DAM</given-names></name><name><surname>Jonkers</surname><given-names>DMAE</given-names></name><name><surname>Russel</surname><given-names>MGVM</given-names></name><name><surname>Stobberingh</surname><given-names>EE</given-names></name><name><surname>Stockbr&#x000fc;gger</surname><given-names>RW</given-names></name></person-group><article-title>The effect of a probiotic drink with <italic>Lactobacillus plantarum</italic> 299v on the bacterial composition in faeces and mucosal biopsies of rectum and ascending colon</article-title><source><italic>Alimentary Pharmacology &#x00026; Therapeutics</italic></source><year>2006</year><volume>23</volume><issue>2</issue><fpage>255</fpage><lpage>263</lpage><pub-id pub-id-type="pmid">16393305</pub-id></element-citation></ref><ref id="B81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanhoutte</surname><given-names>T</given-names></name><name><surname>de Preter</surname><given-names>V</given-names></name><name><surname>de Brandt</surname><given-names>E</given-names></name><name><surname>Verbeke</surname><given-names>K</given-names></name><name><surname>Swings</surname><given-names>J</given-names></name><name><surname>Huys</surname><given-names>G</given-names></name></person-group><article-title>Molecular monitoring of the fecal microbiota of healthy human subjects during administration of lactulose and <italic>Saccharomyces boulardii</italic></article-title><source><italic>Applied and Environmental Microbiology</italic></source><year>2006</year><volume>72</volume><issue>9</issue><fpage>5990</fpage><lpage>5997</lpage><pub-id pub-id-type="pmid">16957220</pub-id></element-citation></ref><ref id="B82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonnenburg</surname><given-names>JL</given-names></name><name><surname>Chen</surname><given-names>CT</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name></person-group><article-title>Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host</article-title><source><italic>PLoS Biology</italic></source><year>2006</year><volume>4</volume><issue>12</issue><fpage>p. e413</fpage></element-citation></ref><ref id="B83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hojo</surname><given-names>K</given-names></name><name><surname>Nagaoka</surname><given-names>S</given-names></name><name><surname>Murata</surname><given-names>S</given-names></name><name><surname>Taketomo</surname><given-names>N</given-names></name><name><surname>Ohshima</surname><given-names>T</given-names></name><name><surname>Maeda</surname><given-names>N</given-names></name></person-group><article-title>Reduction of vitamin K concentration by salivary <italic>Bifidobacterium</italic> strains and their possible nutritional competition with <italic>Porphyromonas gingivalis</italic></article-title><source><italic>Journal of Applied Microbiology</italic></source><year>2007</year><volume>103</volume><issue>5</issue><fpage>1969</fpage><lpage>1974</lpage><pub-id pub-id-type="pmid">17953607</pub-id></element-citation></ref><ref id="B84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>F-PJ</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Sprenger</surname><given-names>N</given-names></name><etal/></person-group><article-title>Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model</article-title><source><italic>Molecular Systems Biology</italic></source><year>2008</year><volume>4, article 157</volume><fpage>1</fpage><lpage>15</lpage></element-citation></ref><ref id="B85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><etal/></person-group><article-title>Symbiotic gut microbes modulate human metabolic phenotypes</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2008</year><volume>105</volume><issue>6</issue><fpage>2117</fpage><lpage>2122</lpage><pub-id pub-id-type="pmid">18252821</pub-id></element-citation></ref><ref id="B86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dal Bello</surname><given-names>F</given-names></name><name><surname>Walter</surname><given-names>J</given-names></name><name><surname>Hertel</surname><given-names>C</given-names></name><name><surname>Hammes</surname><given-names>WP</given-names></name></person-group><article-title>In vitro study of prebiotic properties of levan-type exopolysaccharides from <italic>Lactobacilli</italic> and non-digestible carbohydrates using denaturing gradient gel electrophoresis</article-title><source><italic>Systematic and Applied Microbiology</italic></source><year>2001</year><volume>24</volume><issue>2</issue><fpage>232</fpage><lpage>237</lpage><pub-id pub-id-type="pmid">11518326</pub-id></element-citation></ref><ref id="B87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>E</given-names></name><name><surname>Hayes</surname><given-names>M</given-names></name><name><surname>O'Connor</surname><given-names>P</given-names></name><etal/></person-group><article-title>Salivaricin P, one of a family of two-component antilisterial bacteriocins produced by intestinal isolates of <italic>Lactobacillus salivarius</italic></article-title><source><italic>Applied and Environmental Microbiology</italic></source><year>2007</year><volume>73</volume><issue>11</issue><fpage>3719</fpage><lpage>3723</lpage><pub-id pub-id-type="pmid">17416691</pub-id></element-citation></ref><ref id="B88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>MC</given-names></name><name><surname>Mequio</surname><given-names>MJ</given-names></name><name><surname>Pybus</surname><given-names>V</given-names></name></person-group><article-title>Inhibition of vaginal lactobacilli by a bacteriocin-like inhibitor produced by <italic>Enterococcus faecium</italic> 62-6: potential significance for bacterial vaginosis</article-title><source><italic>Infectious Disease in Obstetrics and Gynecology</italic></source><year>2003</year><volume>11</volume><issue>3</issue><fpage>147</fpage><lpage>156</lpage></element-citation></ref><ref id="B89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collado</surname><given-names>MC</given-names></name><name><surname>Isolauri</surname><given-names>E</given-names></name><name><surname>Salminen</surname><given-names>S</given-names></name></person-group><article-title>Specific probiotic strains and their combinations counteract adhesion of <italic>Enterobacter sakazakii</italic> to intestinal mucus</article-title><source><italic>FEMS Microbiology Letters</italic></source><year>2008</year><volume>285</volume><issue>1</issue><fpage>58</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">18503543</pub-id></element-citation></ref><ref id="B90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>T</given-names></name><name><surname>Ishikawa</surname><given-names>H</given-names></name><name><surname>Tateda</surname><given-names>K</given-names></name><name><surname>Yaeshima</surname><given-names>T</given-names></name><name><surname>Ishibashi</surname><given-names>N</given-names></name><name><surname>Yamaguchi</surname><given-names>K</given-names></name></person-group><article-title>Oral administration of <italic>Bifidobacterium longum</italic> prevents gut-derived <italic>Pseudomonas aeruginosa</italic> sepsis in mice</article-title><source><italic>Journal of Applied Microbiology</italic></source><year>2008</year><volume>104</volume><issue>3</issue><fpage>672</fpage><lpage>680</lpage><pub-id pub-id-type="pmid">17927741</pub-id></element-citation></ref><ref id="B91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zyrek</surname><given-names>AA</given-names></name><name><surname>Cichon</surname><given-names>C</given-names></name><name><surname>Helms</surname><given-names>S</given-names></name><name><surname>Enders</surname><given-names>C</given-names></name><name><surname>Sonnenborn</surname><given-names>U</given-names></name><name><surname>Schmidt</surname><given-names>MA</given-names></name></person-group><article-title>Molecular mechanisms underlying the probiotic effects of <italic>Escherichia coli</italic> Nissle 1917 involve ZO-2 and PKC<italic>&#x003b6;</italic> redistribution resulting in tight junction and epithelial barrier repair</article-title><source><italic>Cellular Microbiology</italic></source><year>2007</year><volume>9</volume><issue>3</issue><fpage>804</fpage><lpage>816</lpage><pub-id pub-id-type="pmid">17087734</pub-id></element-citation></ref><ref id="B92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Hara</surname><given-names>AM</given-names></name><name><surname>O'Regan</surname><given-names>P</given-names></name><name><surname>Fanning</surname><given-names>&#x000c1;</given-names></name><etal/></person-group><article-title>Functional modulation of human intestinal epithelial cell responses by <italic>Bifidobacterium infantis</italic> and <italic>Lactobacillus salivarius</italic></article-title><source><italic>Immunology</italic></source><year>2006</year><volume>118</volume><issue>2</issue><fpage>202</fpage><lpage>215</lpage><pub-id pub-id-type="pmid">16771855</pub-id></element-citation></ref><ref id="B93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>So</surname><given-names>J-S</given-names></name><name><surname>Kwon</surname><given-names>H-K</given-names></name><name><surname>Lee</surname><given-names>C-G</given-names></name><etal/></person-group><article-title>						<italic>Lactobacillus casei</italic> suppresses experimental arthritis by down-regulating T helper 1 effector functions</article-title><source><italic>Molecular Immunology</italic></source><year>2008</year><volume>45</volume><issue>9</issue><fpage>2690</fpage><lpage>2699</lpage><pub-id pub-id-type="pmid">18243320</pub-id></element-citation></ref><ref id="B94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheil</surname><given-names>B</given-names></name><name><surname>McCarthy</surname><given-names>J</given-names></name><name><surname>O'Mahony</surname><given-names>L</given-names></name><etal/></person-group><article-title>Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis</article-title><source><italic>Gut</italic></source><year>2004</year><volume>53</volume><issue>5</issue><fpage>694</fpage><lpage>700</lpage><pub-id pub-id-type="pmid">15082588</pub-id></element-citation></ref><ref id="B95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kravchenko</surname><given-names>VV</given-names></name><name><surname>Kaufmann</surname><given-names>GF</given-names></name><name><surname>Mathison</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Modulation of gene expression via disruption of NF-<italic>&#x003ba;</italic>B signaling by a bacterial small molecule</article-title><source><italic>Science</italic></source><year>2008</year><volume>321</volume><issue>5886</issue><fpage>259</fpage><lpage>263</lpage><pub-id pub-id-type="pmid">18566250</pub-id></element-citation></ref><ref id="B96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname><given-names>HS</given-names></name><name><surname>Rutherfurd</surname><given-names>KJ</given-names></name><name><surname>Prasad</surname><given-names>J</given-names></name><name><surname>Gopal</surname><given-names>PK</given-names></name></person-group><article-title>Enhancement of natural and acquired immunity by <italic>Lactobacillus rhamnosus</italic> (HN001), <italic>Lactobacillus acidophilus</italic> (HN017) and <italic>Bifidobacterium lactis</italic> (HN019)</article-title><source><italic>British Journal of Nutrition</italic></source><year>2000</year><volume>83</volume><issue>2</issue><fpage>167</fpage><lpage>176</lpage><pub-id pub-id-type="pmid">10743496</pub-id></element-citation></ref><ref id="B97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname><given-names>HS</given-names></name><name><surname>Rutherfurd</surname><given-names>KJ</given-names></name><name><surname>Cross</surname><given-names>ML</given-names></name><name><surname>Gopal</surname><given-names>PK</given-names></name></person-group><article-title>Enhancement of immunity in the elderly by dietary supplementation with the probiotic <italic>Bifidobactedum lactis</italic> HN019</article-title><source><italic>The American Journal of Clinical Nutrition</italic></source><year>2001</year><volume>74</volume><issue>6</issue><fpage>833</fpage><lpage>839</lpage><pub-id pub-id-type="pmid">11722966</pub-id></element-citation></ref><ref id="B98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guarner</surname><given-names>F</given-names></name><name><surname>Bourdet-Sicard</surname><given-names>R</given-names></name><name><surname>Brandtzaeg</surname><given-names>P</given-names></name><etal/></person-group><article-title>Mechanisms of disease: the hygiene hypothesis revisited</article-title><source><italic>Nature Clinical Practice Gastroenterology and Hepatology</italic></source><year>2006</year><volume>3</volume><issue>5</issue><fpage>275</fpage><lpage>284</lpage></element-citation></ref></ref-list></back><floats-group><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Schematic diagram illustrating potential or known mechanismswhereby probiotic bacteria might impact on the microbiota. These mechanismsinclude (1) competition for dietary ingredients as growth substrates, (2) bioconversionof, for example, sugars into fermentation products with inhibitory properties, (3)production of growth substrates, for example, EPS or vitamins, for other bacteria,(4) direct antagonism by bacteriocins, (5) competitive exclusion for bindingsites, (6) improved barrier function, (7) reduction of inflammation, thusaltering intestinal properties for colonization and persistence within, and (8)stimulation of innate immune response (by unknown mechanisms). IEC: epithelial cells,DC: dendritic cells, T:T-cells. For further details, see main text.</p></caption><graphic xlink:href="IPID2008-175285.001"/></fig><table-wrap id="tab1" position="float"><label>Table 1</label><caption><p>Beneficial properties reported for probiotic bacteria.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1"> Host benefit </th><th align="left" rowspan="1" colspan="1"> Microbial trait implicated </th><th align="center" rowspan="1" colspan="1"> Reference<sup>1</sup></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Immune modulation  </td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Stimulation of immunity </td><td align="left" rowspan="1" colspan="1">Enhance T-cell numbers and activity levels</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="B13">13</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Dampening of inflammation</td><td align="left" rowspan="1" colspan="1">Promote anti-inflammatory cytokine production</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="B14">14</xref>]</td></tr><tr><td align="left" rowspan="3" colspan="1">Pathogen burden reduction</td><td align="left" rowspan="1" colspan="1">Competitive exclusion</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="B15">15</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Direct antagonism</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Uncharacterised</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Improved gut barrier function</td><td align="left" rowspan="1" colspan="1">Promote gut barrier integrity</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="B20">20</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Reduced cancer risk</td><td align="left" rowspan="1" colspan="1">Detoxification of carcinogenic metabolites</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="B21">21</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Reduced atopic allergy symptoms</td><td align="left" rowspan="1" colspan="1">Suppression of hypersensitivity</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="B22">22</xref>]</td></tr><tr><td align="left" rowspan="2" colspan="1">Reduced cardiovascular disease risk</td><td align="left" rowspan="1" colspan="1">Cholesterol reduction by deconjugation of bile salts</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B24">24</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Production of anti-hypertensive peptides</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="B25">25</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Alleviation of dietary intolerance</td><td align="left" rowspan="1" colspan="1">Catabolism of dietary ingredients</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="B26">26</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Enhanced nutrient value</td><td align="left" rowspan="1" colspan="1">Vitamin and co-factor production</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="B27">27</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Alleviation of IBS<sup>2</sup> symptoms</td><td align="left" rowspan="1" colspan="1">Not defined</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B29">29</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>						<sup>1</sup>Sample reference for each trait. See main text for review references,</p><p>						<sup>2</sup>Irritable bowel syndrome.</p></fn></table-wrap-foot></table-wrap></floats-group></article>